REPARE THERAPEUTICS

Repare Therapeutics is a clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics. It has developed highly targeted cancer therapies focused on genomic instability, including DNA damage repair.